Skip to content
BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Trafalgar International, Inc. TRFA

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$-331,612

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2021 · Revenue 0.0 · Net income -0.6
-1M-2M
20152018202120242025
Compound annual growth
−49.0%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2021 · Operating -2716.9%
-100000%-200000%
201520202025
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks

Total assetsUSD 815.00
EquityUSD -741,649.00
Current ratio0.00×

Equity funds -91000% of total assets.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
TRFA, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B◌◌◌◌0.00.00.00.00.0◌◌
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0◌
EBITDA $B◌◌◌◌◌◌◌◌◌◌◌
Income tax $B◌◌◌◌◌◌◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $0.000.000.000.000.00−0.01−0.05−0.03−0.030.00◌
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————
ROE % — not applicable: negative equity———————————
Shares out B0.000.000.800.730.510.460.040.030.000.03◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 39 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. 10 checks were skipped: revenue is not tagged before 2017. Nine checks were skipped: EPS is not tagged before 2016.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inFlorida
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015

Share this section

Download image